Patent · US Active

Materials and methods for treatment of cystic fibrosis and for induction of ion secretion

US10086007B2 · kind B2 · utility

2Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateOct 2, 2018
Priority date
Expiry dateMar 15, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/164
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides materials and methods for inducing ion secretion and/or for treating cystic fibrosis. In one embodiment, the composition comprises glucose and/or a non-metabolizable glucose analog and/or non-structural protein (NSP4), a NSP4 peptide, or a NSP4 toxoid as the active ingredient, formulated with pharmaceutically-acceptable carriers. In a preferred embodiment, the composition is in a form of an aerosol preparation for intranasal and/or pulmonary administration, and is used to stimulate chloride and fluid secretion in nasal, tracheal and/or bronchial epithelium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.